Head of Operations
Matt brings substantial experience in global, cross-functional roles such as business operations, supply chain management, product development and strategic planning.
As Head of Operations, Matt leads the Portfolio & Program Management, Quality Assurance, and Supply Chain functions. Additionally, Matt leads key strategic initiatives such as how AVROBIO evolves their ex-vivo clinical delivery model to enable global registrational studies across multiple programs.
He was most recently with AstraZeneca where he served as operations therapy area leader for oncology and the head of operations for the company’s IMED biotech unit. He joined AstraZeneca from their subsidiary MedImmune where he served as VP, chief of staff to the president. He also spent 11 years with Amgen, serving in a number of key roles including global program manager for XGEVA® (denosumab), director of supply chain risk management and an expat assignment as the head of strategic planning and operations for international R&D. Matt began his career in the U.S. Navy, serving as engineering officer on a destroyer, commanding officer of a special operations ship and faculty at the U.S. Naval Academy, where he also coached the varsity offshore sailing team.
Matt has a BS from the U.S. Naval Academy, an MS in biotechnology from Georgetown University and an MBA from the University of Michigan. He currently serves as adjunct faculty in Georgetown University’s biotechnology MS program where he teaches courses in management strategy and project & portfolio management.
Today is Rare Disease Day and we want to recognize the incredible work patient advocacy groups do year-round to raise awareness for the hundreds of millions of people around the world living with — and caring for — rare diseases.
Learn more: RAREDISEASEDAY.ORG | #RAREDISEASEDAY